Sentinus LLC’s Edwards Lifesciences EW Stock Holding History

Sentinus LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$589K	Sell	6,507 -678	-9%	-$56.8K	0.05%	290
2026 Q1	$575K	Sell	7,185 -73	-1%	-$6.02K	0.05%	256
2025 Q4	$619K	Buy	7,258 +1,408	+24%	+$116K	0.06%	250
2025 Q3	$455K	Buy	5,850 +693	+13%	+$54.1K	0.1%	140
2025 Q2	$403K	Buy	5,157 +85	+2%	+$6.34K	0.1%	146
2025 Q1	$368K	Buy	5,072 +124	+3%	+$8.88K	0.1%	139
2024 Q4	$366K	Sell	4,948 -71	-1%	-$4.97K	0.11%	133
2024 Q3	$331K	Buy	5,019 +12	+0.2%	+$872	0.1%	149
2024 Q2	$462K	Buy	5,007 +79	+2%	+$7K	0.15%	108
2024 Q1	$471K	Buy	+4,928	New	+$414K	0.17%	99
2023 Q2	$488K	Sell	5,173 -56	-1%	-$4.87K	0.15%	108
2023 Q1	$433K	Buy	+5,229	New	+$411K	0.14%	112

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Sentinus LLC's EW Position: Q2 2026 in Review

Sentinus LLC reduced its Edwards Lifesciences (EW) stake by 9.4% in Q2 2026, selling an estimated $56.8K and leaving 6,507 shares worth $589K. The position accounts for 0.05% of the portfolio, ranked #290.

Sentinus LLC first reported a position in EW in Q1 2023 and has held it in 12 quarters since. The position peaked at $619K in Q4 2025. 913 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Sentinus LLC held 6,507 shares of Edwards Lifesciences worth $589K as of Q2 2026.
Sentinus LLC sold 678 Edwards Lifesciences shares in Q2 2026, an estimated $56.8K.
Edwards Lifesciences made up 0.05% of Sentinus LLC's portfolio in Q2 2026, its #290 holding.
Sentinus LLC first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 12 quarters since.
Sentinus LLC's Edwards Lifesciences position peaked at $619K in Q4 2025.
913 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.